OREANDA-NEWS. More than 100 million people have been vaccinated outside Russia with the Sputnik V and Sputnik Lite vaccines. The Russian drug has equaled the coverage in the world with Moderna. Although it is inferior to Sinopharm and Pfizer. This was stated in an interview with Bloomberg by the head of the Russian direct Investment Fund (RDIF) Kirill Dmitriev.

«We have provided Sputnik to more than 100 million people outside of Russia. For comparison, Moderna has provided the vaccine to 100 million people in middle-income countries outside the United States and Europe, Sinopharm – 200 million people outside China, and Pfizer – 350 million people outside the United States and Europe», he said.

The head of the Russian direct Investment Fund also added that he expects an increase in the market share of middle-income countries in the future to 15-20%. Dmitriev spoke about the complete elimination of delays in the supply of Russian vaccines abroad. It is expected that the approval of the Russian vaccine by WHO will be received by the end of the year after the completion of a number of bureaucratic procedures, he added.